English
新闻公告
More
化学进展 2001, Vol. 13 Issue (02): 135- 前一篇   后一篇

• 综述与评论 •

内分泌干扰剂的研究进展

任晋;蒋可   

  1. 中科院生态环境研究中心
  • 收稿日期:2000-04-01 修回日期:2000-09-01 出版日期:2001-03-24 发布日期:2001-03-24
  • 通讯作者: 蒋可

Advances of Endocrine Disrupting Chemicals Research

Ren Jin;Jiang Ke   

  1. Research Center for EcoEnvironm ental Sciences, Chinese Academ y of Sciences,Beijing 100085, China
  • Received:2000-04-01 Revised:2000-09-01 Online:2001-03-24 Published:2001-03-24
  • Contact: Jiang Ke
内分泌干扰剂(EDC) 正在成为生态环境研究的前沿课题, 并受到各国政府的密切关注。本文综述了内分泌干扰剂的危害、作用机理、化合物类型及研究进展, 特别强调了化合物低剂量长期暴露潜在危害的新概念, 详述了传统的环境毒理学和环境分析化学所遇到的挑战及生物分析、化学仪器分析和生物传感器技术在内分泌干扰剂筛选过程中的重要战略地位。
It has been suggested that endocrine disrupting chemicals capable of modulating the endocrine system may contribute to adverse health, reproduction, and developmental effects in human and wildlife. This article reviews the evidence, mechanism , testing strategies and several major analysis methods. The screening and testing methods of endocrine disrupting chemicals and the challenge to analysis technology are discussed.

中图分类号: 

()

[ 1 ] Newman P A . J. Natl. Cancer Inst. , 1990, 82: 998—1000
[ 2 ] Osterlind A. Br. J. Cancer, 1986, 53: 501—505
[ 3 ] Carlsen E, Giwercman A. Br. Med. J. , 1992, 305: 609—613
[ 4 ] Colbo r T, vom Saal F S, Soto A M. Environmental Health Perspectives, 1993, 101: 378—384
[ 5 ] Giesy J P, Ludwig J P, Tillitt D E. Environ. Sci. Technol. ,1994, 28: 128A —135A
[ 6 ] Carroquino M J , Galson S K, Licht J , et al. Environmental Health Perspectives, 1998, 106 Supp l. 3: 867—873
[ 7 ] U. S. EPA. Endocrine Disruptor Screening and Testing Advisort Committee (EDSTAC) Final Report, 1998, Washington,DC:U.S. Environmental Protection Agency
[ 8 ] Colborn T, Dumanoski D, Myers J Peds. Our Stolen Future:Are We Threatening Our Fertility, Intelligence, and Surival?A Scientific Detective Story. New York: Dutton Books, 1996,306
[ 9 ] Colborn T, Clement C Reds. Chemically-induced Alterations in Sexual and Functional Development: The Wildlife?Human Connection. Princeton: Princeton Scientific Pub Co, 1992
[ 10 ] Sharpe R M. Journal of Endocrinology, 1993, 137: 357—360
[ 11 ] Steinmetz R, Young P C M , Caperell-Grant A , Gize E A , et al. Cancer Research, 1995, 56: 5403—5409
[ 12 ] Guillette L H J r. Human and Ecological Risk Assessment,1995, 1 (2) : 25—36
[ 13 ] Guillette L H J r, Gross T S, Marsson G R, et al. Environ.Health Perspectives, 1994, 102 (8) : 680—688
[ 14 ] Guillette L J J , Pickford D B, Grain D N , et al. Gen. Comp.Endocrinol. , 1996, 101: 32—42
[ 15 ] Strape R M , Fisher J S, Millar M M , Jobling S, Sumpter J P.Environ. Health Perspect. , 1995, 103 (12) : 1136—1143
[ 16 ] Dam K, Seidler F J. Brain Res. Dev. Brain Res. , 1998, 108:39—45
[ 17 ] Whitney K D. Toxicol. Appl. Pharmacol. , 1995, 134: 53—62
[ 18 ] Ruehlmann D O , Steinert J R, Valaerde M A , et al. FA SEB Journal, 1998, 12: 613—619
[ 19 ] Tyler C R, Jobling S, Sumpter J P, Critical Reviews in Toxicology, 1998, 28 (4) : 319—361
[ 20 ] Skakkebaek N E, Rajpert-Demeyts R, Jrgensen N , et al.APM IS, 1998, 106: 3—12
[ 21 ] Swan S H, Elkin E P, Fenster I, et al. Environmental Health Perspectives, 1997, 105: 1228—1232
[ 22 ] IEH. Environmental oestrogens: Consequences to human health and wildlife, Leicester: University of Leicester, 1995
[ 23 ] Ben-Jonathan N , Cooper R L , Foster P, et al. Environmental Health Perspectives, 1999, 107, Supplement 4: 605—611
[ 24 ] Shapiro S, Kelly J P. N. Engl. J. Med. 1985, 313: 969—972
[ 25 ] Colditz G A. J. Natl. Cancer Inst. , 1998, 90: 814—823
[ 26 ] Hoyer P B, Sipes I G. Annu. Rev. Pharmacol. Toxicol. ,1996, 36: 307—331
[ 27 ] Brouwer A , Longnecker M P, Birnbaum L S, et al. Environmental Health Perspectives, 1999, 107, Supplement 4: 639—649
[ 28 ] Ashford N A , Miller C S. Chemical Exposures: Low Levels and High Stakes. New York: Wiley & Sons, 1998
[ 29 ] Schmidt C W. Environmental Health Perspectives, 1998,106: A 18—A 23
[ 30 ] Dolk H, Vrijheid M , Armstrong B, et al. The Lancet, 1995,352: 423—427
[ 31 ] Boyce N. New Scientist, 1997, 153: 5
[ 32 ] Davis D L , Gottlieb M B, Stampnitzky J R. Journal of the American Medical Association, 1998, 279: 1018—1023
[ 33 ] The National Asthma Audit 1997/1998, National Asthma Campaign, August 1997
[ 34 ] Jacobson J L , Jacobson S W. Teratology, 1997, 55: 338—347
[ 35 ] Ashford N A , Miller C S. Environ. Sci. & Tech. , 1998.508A —509A
[ 36 ] Kavlock R J , Daston G P, DeRosa C, et al. Environmental Health Perspectives, 1996, 104, Supplement 4: 714—740
[ 37 ] Waller C I, Oprea T I, Chae K. J . Biol. Chem. , 1995, 270(34) : 19998—20003
[ 38 ] Kelce W R, Stone C R, Laws S C, et al. Nature, 1995, 375(6532) : 581—585
[ 39 ] McKinney J D. Environ. Health Perspect. , 1989, 82: 323—336
[ 40 ] Gierthy J F, Spink B C, Figge H L , et al. J. CellBiochem. ,1996, 60 (2) : 173—184
[ 41 ] Andersen M E, Birnbaum L S, Barton H A , et al. Toxicol.Appl. Pharmacol. , 1997, 144: 145—155
[ 42 ] Maclatchy D L , Vanderkraak G J. Toxicol. Appl. Pharmacol. , 1995, 134 (2) : 305—312
[ 43 ] Majdic G, Sharpe R M , Oshaughnessy P J , et al. Endocrinology, 1996, 137 (3) : 1063—1070
[ 44 ] Bettin C, Oeh lmann J , Stroben E. Helgo landerM eeresuntersuchungen, 1996, 50 (3) : 299—317
[ 45 ] P icard D, Bunone G, L iu J W , Donze O. Biochem. Soc.T rans. , 1997, 25: 597—602
[ 46 ] Kuiper G G, Carlsson B, Grandien K, et al. Endocrino logy,1997, 138: 863—870
[ 47 ] Pope C N , Chak rabo rti T K. Toxico logy, 1992, 73: 35—43
[ 48 ] Celius T, Haugen T B. Enviro. Health Perspectives, 1999,107: 63—68
[ 49 ] Johnson D E, Seidler F J , Slotkin T A. Brain Research Bulletin, 1998, 45: 143—147
[ 50 ] Afifi N A , Ramadan A , Abd-EI-Aziz M Z, et al. Deutsche Tieraerztliche Wochenschrift, 1991, 98: 419—420
[ 51 ] ENDS 1999, ENDS Repo rt, 290: 26—30
[ 52 ] Pant N , Prasad A K, Srivatava S C, et al. Human & Experimental Toxicology, 1995, 14: 889—894
[ 53 ] Pant N , Shankar R, Srivastava S P. Human & Experimental Toxicology, 1997, 16: 267—272
[ 54 ] Rawings N C, Cook S J , Waldbiling D. Journal of Toxicology and Environmental Health, 1998, 54: 21—36
[ 55 ] EI-Gohary M , Awara W M , Nassar S, et al. Toxicology,1999, 132: 1—8
[ 56 ] Gary L E, Wolf C, Lambright G, et al. Toxicology and Industrial Health, 1999, 15: 94—118
[ 57 ] Cooper R L , Goldman J M , Stoker T E. Toxicology and Industrial Health, 1999, 15: 26—36
[ 58 ] Gray L E. Toxicology Letters, 1998, 102—103: 331—335
[ 59 ] Vinggaard A M , Joergensen E C. Toxicology and Applied Pharmacology, 1999, 155: 150—160
[ 60 ] Gray L E, Ostby J , Monosson E, Kelce W R. Toxicology and Industrial Health, 1999, 15: 65—79
[ 61 ] Ostby J , Kelce W R, Lambright C. Toxicology and Industrial Health, 1999, 15: 80—93
[ 62 ] Paul R, Silve S, De Nys N , et al. Journal of Pharmacology and Experimental Therapeutics, 1998, 285: 1296—1302
[ 63 ] Lim J , Miller M G. Toxicology and Applied Pharmacology,1997, 142: 401—410
[ 64 ] Nakai M , Toshimori K. Cell and Tissue Research, 1998,294: 145—152
[ 65 ] Mantovani A , Maranghi F, Ricciardi C. Food and Chemical Toxicology, 1999, 36: 37—45
[ 66 ] Krishnan A V , Starhis P, Permuth S F, et al. Endocrin. ,1993, 132: 2279—2286
[ 67 ] Sohoni P, Sumpter J P. Journal of Endocrinology, 1998, 158:327—339
[ 68 ] Steinmetz R, Mitchner N A , Grant A , et al. Endocrin. ,1998, 139: 2741—2747
[ 69 ] Anon. New Scientist, 1998/7/18: 4; Howdeshell K L ,Hotchkiss A K. Nature, 1999, 401: 763—764
[ 70 ] ENDS. ENDS Report, 1998, 276: 6
[ 71 ] ENDS. ENDS Report , 1999, 290: 26—30
[ 72 ] Darnerud P O , Thuvander A. Organohalogen Compounds,1998, 35: 415—418
[ 73 ] Eriksson P, Jakobsson E, Fredrik sson A. Organohalogen Compounds, 1998, 35: 375—377
[ 74 ] WHO , Enviro. Health Criteria, 1998. 205
[ 75 ] Hallgren S, Darnerud P O. Organohalogen Compounds,1998, 35: 391—394
[ 76 ] Routledge E J , Parker J , Odum J , et al. Toxicology and Applied Pharmacology, 1998, 153: 12—19
[ 77 ] Fisher J S, Turner K J , Brown N , et al. Enviro. Health Perspectives, 1999, 107: 397—405
[ 78 ] Sohoni P. Sumpter J P. Journal of Endocrinology, 1998, 158:327—339
[ 79 ] Safe S H. Crit. Rev. Toxicol. , 1994, 24: 87—149
[ 80 ] Golden R J , Noller K L , Titus-Emstoff I, et al. Crit. Rev.Toxicol. , 1998, 28 (2) : 109—277
[ 81 ] Brouwer A , Morse D C, Lans M C, et al. Toxicol. Ind.Health, 1998, 14 (1/2) : 59—84
[ 82 ] Van Birgelen A P J M , Smit E A , Kampen I M , Groeneveld C N , et al. Eur. J. Pharmacol. Environ. Toxicol. Pharmacol.Section, 1995, 293: 77—85
[ 83 ] 蒋可(Jiang K). 化学进展(Prog. Chem. ) , 1995, 7: 30
[ 84 ] Safe S H. Ann. Rev. Pharmacol. Toxicol. , 1986, 26: 371—399
[ 85 ] Gray L E, Kelce W R, Monosson E, et al. Toxicol. Appl.Pharmacol . , 1995, 131 (1) : 108—118
[ 86 ] Gibbs P E, Pascoe P L , Burt G R. JMBA , 1988, 68: 715—731
[ 87 ] Mensink B P, Everaarts J M , Kralt H, et al. Mar. Environ.Res. , 1996, 42 (1—4) : 151—154
[ 88 ] Bettin C, Oehlman J , Stroben E. Helgolander Meeresuntersuchungen, 1996, 50 (3) : 299—317
[ 89 ] Ronis M J J , Marson A Z. Mar. Environ . Res. , 1996, 42(1—4) : 161—166
[ 90 ] Vom Saal F S, Timms B F, Montano M M , et al. Proc. Natl.Acad. Sci. USA , 1997, 94: 2056—2061
[ 91 ] Arnold S, Klotz D, Collins B, et al. Science, 1996, 272:1489—1492
[ 92 ] Walke C, Ahmed S A , Brown T, et al. Environmental Health Perspectives, 1999, Supplement 4, 107: 619—624
[ 93 ] Keith L H. 13th Annual Symposium on Waste Testing & Quality Assurance, 1997 July
[ 94 ] http://www.ecrc.usgs.gov/endocrine/u.htm, 1998, 3
[ 95 ] Sadik O A , Witt D M. Environ. Sci. &Tech. , 1999. 368A —374A
[ 96 ] Sadik O A , Van Emon J M. CHEM TECH, 1997, 27 ( 6) :38—46
[ 97 ] Andersen H R, Andersson A M , Arnold S F, et al. Environmental Health Perspectives, 1999, 107, Supplement 1: 89—108
[ 98 ] Shelby M D, Newbold R R, Tully D B, et al. Environmental Health Perspectives, 1996, 104: 1296—1300
[ 99 ] Zacharewski T. Environ. Sci. Tech. , 1997, 31: 613—623
[ 100 ] Fielden M , Wu Z F, Chen I, et al. Toxicol. Appl. Pharmacol. (Suppl) , 1997, 36: 159
[ 101 ] Lopez-Avila V. Critical Reviews in Analytical Chemistry,1999, 29 (3) : 195—230
[ 102 ] Marchand P, Bizec B L. Journal of Chrom. A , 2000, 867:235—245
[ 103 ] Berg M , Müller S R, Schwarzenbach R P. Analytical Chemistry, 1995, 67: 1860—1865
[ 104 ] Geerdink R B, Kooistra-Sijpersma A , Tiesnitsch J , et al.Journal of Chromatography A , 1999, 863: 147—155
[ 105 ] Jiang K, Li L J , Chen Y D, et al. , Chinese Science Bulletin, 1995, 40: 1740
[ 106 ] Jiang K, Li L J , Chen Y D, et al. , Chemo sphere , 1997,34: 941
[ 107 ] 黄翠玲(Huang C L ) , 潘元海(Pan Y H) , Xu Wenjing. 现代有机质谱技术及应用,. 中国人民公安大学出版社, 1999.134—138

[1] Barbara K. Dunn. 乳腺癌预防的三期临床试验:雌激素靶向药物,选择性雌激素受体调控剂和芳香酶抑制剂[J]. 化学进展, 2013, 25(09): 1429-1449.
[2] 王德庆 余应新 钟玉芳 吴明红 盛国英 傅家谟. Caco-2细胞模型用于毒害污染物转运与吸收研究*[J]. 化学进展, 2010, 22(04): 740-747.
[3] 陈保卫,那仁满都拉,吕美玲,X.,Chris,Le. 砷的代谢机制、毒性和生物监测[J]. 化学进展, 2009, 21(0203): 474-482.
阅读次数
全文


摘要

内分泌干扰剂的研究进展